Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Recognize when index signals hint at a trend reversal and how to adjust exposure accordingly. This guidance helps protect gains and minimize losses.
24,330 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
When bad news hits a stock, investors ask if it’s a bargain. This piece weighs UPS’s challenges against its resilient...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...
Large XRP holders appear to be withdrawing from selling on major exchanges even as market volatility persists. With B...
A new watchdog report shows the first quarter of 2026 saw construction setbacks for data centers surge past 2025 leve...
Amid slower housing demand and higher costs, regional and mid-sized builders are leaning on flexible financing to sus...
Sellers turning to private listings may avoid public exposure, but new data suggests this approach can lead to lower ...
A U.S.-based drone parts supplier sparked a notable stock move as analysts adjusted targets and policy shifts tighten...
Global markets are buzzing as offshore crypto platforms increasingly offer pre-IPO exposure tied to SpaceX rumors. Tr...
Corporations are paying top dollar for battle-tested CFOs to steer turnarounds. Nike’s high-profile hire underscores ...
Rising electricity costs driven by AI data centers are reshaping the landscape for utility stocks. This deep dive exp...
The blockchain-focused ETF is tilting toward AI infrastructure assets, signaling a new growth lane for crypto-linked ...